1. Home
  2. OLMA vs HIMX Comparison

OLMA vs HIMX Comparison

Compare OLMA & HIMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • HIMX
  • Stock Information
  • Founded
  • OLMA 2006
  • HIMX 2001
  • Country
  • OLMA United States
  • HIMX Taiwan
  • Employees
  • OLMA N/A
  • HIMX N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • HIMX Semiconductors
  • Sector
  • OLMA Health Care
  • HIMX Technology
  • Exchange
  • OLMA Nasdaq
  • HIMX Nasdaq
  • Market Cap
  • OLMA 465.4M
  • HIMX 1.2B
  • IPO Year
  • OLMA 2020
  • HIMX 2006
  • Fundamental
  • Price
  • OLMA $6.10
  • HIMX $7.72
  • Analyst Decision
  • OLMA Strong Buy
  • HIMX Buy
  • Analyst Count
  • OLMA 5
  • HIMX 1
  • Target Price
  • OLMA $26.25
  • HIMX $15.00
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • HIMX 2.6M
  • Earning Date
  • OLMA 11-12-2024
  • HIMX 02-04-2025
  • Dividend Yield
  • OLMA N/A
  • HIMX 3.76%
  • EPS Growth
  • OLMA N/A
  • HIMX 10.98
  • EPS
  • OLMA N/A
  • HIMX 0.44
  • Revenue
  • OLMA N/A
  • HIMX $897,257,000.00
  • Revenue This Year
  • OLMA N/A
  • HIMX $12.75
  • Revenue Next Year
  • OLMA N/A
  • HIMX N/A
  • P/E Ratio
  • OLMA N/A
  • HIMX $17.20
  • Revenue Growth
  • OLMA N/A
  • HIMX N/A
  • 52 Week Low
  • OLMA $5.56
  • HIMX $4.80
  • 52 Week High
  • OLMA $16.78
  • HIMX $9.80
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • HIMX 60.37
  • Support Level
  • OLMA $5.56
  • HIMX $6.47
  • Resistance Level
  • OLMA $6.87
  • HIMX $8.26
  • Average True Range (ATR)
  • OLMA 0.81
  • HIMX 0.72
  • MACD
  • OLMA -0.28
  • HIMX 0.09
  • Stochastic Oscillator
  • OLMA 10.12
  • HIMX 53.36

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue gets derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

Share on Social Networks: